Skip to content
10-Q/A

Quarterly Report

CORIX BIOSCIENCE, INC.

0001659173-17-000494

← back to feed
Filed
Nov 9, 2017 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Sep 30, 2016 9.17M sh
Operating Cash Flow Q3 2016 · Sep 30, 2016 −$1.5M
Operating Cash Flow Q3 2016 · Sep 30, 2015 −$1.97M
Cash And Equivalents Q3 2016 · Sep 30, 2016 $90.65K
Cash And Equivalents Q3 2016 · Dec 31, 2015 $199.57K
Cash And Equivalents Q3 2016 · Sep 30, 2015 $424.68K
Cash And Equivalents Q3 2016 · Dec 31, 2014 $304.37K
Stockholders Equity Q3 2016 · Sep 30, 2016 $4.38M
Stockholders Equity Q3 2016 · Dec 31, 2015 $4.47M
Total Liabilities Q3 2016 · Sep 30, 2016 $6.01M
Total Liabilities Q3 2016 · Dec 31, 2015 $4.41M
Total Assets Q3 2016 · Sep 30, 2016 $12.05M
Total Assets Q3 2016 · Dec 31, 2015 $9.42M
Sga Expense Q3 2016 · Sep 30, 2016 $1.59M
Sga Expense Q3 2016 · Sep 30, 2016 $4.4M
Sga Expense Q3 2016 · Sep 30, 2015 $1.14M
Sga Expense Q3 2016 · Sep 30, 2015 $2.1M
Net Income Q3 2016 · Sep 30, 2016 −$1.55M
Net Income Q3 2016 · Sep 30, 2016 −$4.29M
Net Income Q3 2016 · Sep 30, 2015 −$1.12M
Net Income Q3 2016 · Sep 30, 2015 −$2.29M
Revenue Q3 2016 · Sep 30, 2016 $175.7K
Revenue Q3 2016 · Sep 30, 2016 $503.21K
Revenue Q3 2016 · Sep 30, 2015 $133.44K
Revenue Q3 2016 · Sep 30, 2015 $327.19K